Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
65 Cards in this Set
- Front
- Back
Cephalexin (Keflex)
-- Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: first-generation cephalosporin
Th Cl: antibiotic PG Cl: B CS Cl: N/A |
|
Cephalexin (Keflex)
-- Indications -- Action |
Hinders or kills susceptible bacteria by inhibiting cell-wall synthesis. Broad spectrum antibiotic.
|
|
Cephalexin (Keflex)
-- Typical dose adults |
250 mg p.o. q6hr--maximum 4 g daily.
|
|
Cephalexin (Keflex)
-- Adverse Reactions |
anorexia, diarrhea, nausea, pseudomembranous colitis, thrombocytopenia, transient neutropenia, anaphylaxis
|
|
Cephalexin (Keflex)
-- Nursing Process |
* to minimize GI reactions, give drug with food or milk
* instruct patient to take drug as prescribed even after he feels better |
|
Restoril (Temazepam) -- Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category
|
Ph Cl: benzodiazepine
Th Cl: sedative-hypnotic PG Cl: X CS Cl: 4 |
|
Restoril (Temazepam)
-- Indications -- Action |
Acts on limbic system, thalamus and hypothalamus of CNS to produce hypnotic/sleep results.
|
|
Restoril (Temazepam)
-- Typical dose adults |
7.5 – 30 mg p.o. before bedtime
|
|
Restoril (Temazepam)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: Daytime drowsiness, dizziness, abnormal dreams, headache
Drug Interactions: CNS depressants & opioid analgesics may increase depression—use w caution |
|
Restoril (Temazepam)
-- Nursing Process |
* watch patient doesn’t try to get out of bed and fall
|
|
Zolpidem Tartrate (Ambien) -- Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category
|
Ph Cl: imidazopyridine
Th Cl: hypnotic PG Cl: B CS Cl: N/A |
|
Zolpidem Tartrate (Ambien)
-- Indications -- Action |
Interacts w the benzodiapine receptor site on the GABA receptor to produce hypnotic effect—no muscle relaxant or anticonvulsant properties.
|
|
Zolpidem Tartrate (Ambien)
-- Typical dose adults |
10 – 12.5 mg p.o. before bedtime
|
|
Zolpidem Tartrate (Ambien)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: Daytime drowsiness, dizziness, abnormal dreams, headache
Drug Interactions: CNS depressants & opioid analgesics may increase CNS depression—use w caution |
|
Zolpidem Tartrate (Ambien)
-- Nursing Process |
* take on an empty stomach (immediately before bed) for max absorption
* short term drug * watch patient doesn’t try to get out of bed and fall |
|
Ferrous Sulfate (Iron Supplement) -- Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category
|
Ph Cl: oral iron supplement
Th Cl: hematinic PG Cl: A CS Cl: N/A |
|
Ferrous Sulfate (Iron Supplement)
-- Indications -- Action |
Binds to carrier protein (transferrin) then to bone marrow for incorporation into hemoglobin
|
|
Ferrous Sulfate (Iron Supplement)
-- Typical dose adults |
150 -300 mg po daily in divided doses
|
|
Ferrous Sulfate (Iron Supplement)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: Temporary staining of teeth; GI disturbance (nausea, vomiting, constipation, black stools)
Drug Interactions: Vit C increases absorption, avoid taking w dairy decreases absorption (also antacids, tetracycline) |
|
Ferrous Sulfate (Iron Supplement)
-- Nursing Process |
* Patient Ed: black stools & GI disturbance common
* Do not give with milk or antacids *Vit C may increase absorption * Best absorbed on an empty stomach but give w food b/c of GI disturbance |
|
Acetaminophen (Tylenol, APAP) -- Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category
|
Ph Cl: para-aminophenol deriv
Th Cl: non-opioid analgesic; anti-pyretic PG Cl: B CS Cl: N/A |
|
Acetaminophen (Tylenol, APAP)
-- Indications -- Action |
Analgesia by inhibiting prostaglandin syn; anti-pyretic effect by acting on hypothalamic heat reg. center
|
|
Acetaminophen (Tylenol, APAP)
-- Typical dose adults |
40 – 650 mg q 4-6 h prn
po or pr |
|
Acetaminophen (Tylenol, APAP)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: Liver damage; hypoglycemia, blood cell damage
Drug Interactions: warfarin increased risk of bleeding; |
|
Acetaminophen (Tylenol, APAP)
-- Nursing Process |
* Tell patient for short term use only (od or lt use can cause liver damage)
* Not for fever over 103.1, lasting longer than 3 days or recurring |
|
Acetylsalicylic Acid (aspirin) Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category
|
Ph Cl: salicylate
Th Cl: non-opioid analgesic; antiplatelet drug; anti-pyretic;anti-inflammatory PG Cl: C / D in 3rd Trimester CS Cl: N/A |
|
Acetylsalicylic Acid (aspirin)
-- Indications -- Action |
Analgesia and anti-inflammatory effects by inhibiting prostaglandin syn; anti-pyretic effect by acting on hypothalamus to cause vasodilation
|
|
Acetylsalicylic Acid (aspirin)
-- Typical dose adults |
325 – 650 mg q 4-6 h prn
po or pr (80 mg prophylaxis) |
|
Acetylsalicylic Acid (aspirin)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: GI bleeding, GI distress, tinnitus (hearing loss), Reyes Syndrome, angioedema, anaphylaxis, thrombocytopenia
Drug Interactions: warfarin and heparin increased risk of bleeding; |
|
Acetylsalicylic Acid (aspirin)
-- Nursing Process |
* Give with food, milk, antacid or large glass H20 to minimize GI disturbance
* Best absorbed on an empty stomach but give w food b/c of GI disturbance |
|
Nitroglycerin
Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: nitrate
Th Cl: antianginal; vasodilator PG Cl: C CS Cl: N/A |
|
Nitroglycerin
-- Indications -- Action |
Acts on vascular smooth muscle tissue of VEINS; decreases cardiac oxygen demand by decreasing diastolic pressure; increases blood flow through CORONARY vessels increasing oxygen supply
|
|
Nitroglycerin
-- Typical dose adults |
SL 0.3 – 0.6 mg q5 min for up to 15 min.
|
|
Nitroglycerin
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: GI bleeding, GI distress, tinnitus (hearing loss), Reyes Syndrome, angioedema, anaphylaxis, thrombocytopenia
Drug Interactions: interactions w other hypertensives can decrease bp too much |
|
Nitroglycerin
-- Nursing Process |
* monitor vital signs & drug response (esp bp—excessive hypotension may worsen MI)
* take drug regularly, keep handy, do not abruptly stop * use lowest dose to avoid building up tolerance to drug |
|
Digoxin (Lanoxin)
Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: cardiac glycoside
Th Cl: anti-arrhytmic; inotropic PG Cl: C CS Cl: N/A |
|
Digoxin (Lanoxin)
-- Indications -- Action |
Strengthens myocardial contractions by acting on CNS to enhance vagal tone (slowing through SA / AV nodes, resulting in an anti-arrythmic effect
|
|
Digoxin (Lanoxin)
-- Typical dose adults |
p.o. 0.05 – 0.5 mg for slow effect; 0.75 – 1.25 mg for rapid effect
|
|
Digoxin (Lanoxin)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: nausea, vomiting, anorexia, visual disturbances
Drug Interactions: avoid antacids (decrease absorption), avoid diuretics and corticosteroids that lower K level (precipitating toxicity) |
|
Digoxin (Lanoxin)
-- Nursing Process |
* monitor vital signs & drug response (must check apical pulse: ok between 60 – 100 bpm)
* blood serum level of digoxin 0.5-2 ng/ml * low K levels can precipitate toxicity: instruct patient to eat foods high in K |
|
Furosemide (Lasix)
Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: loop diuretic
Th Cl: diuretic; anti-hypertensive PG Cl: C CS Cl: N/A |
|
Furosemide (Lasix)
-- Indications -- Action |
Inhibits NaCl reabsorption (at the loop of henle) & promotes H20 and NaCl excretion (also K, Ca, Mg)
|
|
Furosemide (Lasix)
-- Typical dose adults |
p.o, iv or im usual initial 20 – 80 mg bid
|
|
Furosemide (Lasix)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: hyperglycemia, hypotension, hypokalemia,
Drug Interactions: may intensify other hypotensive therapies, decreases hypoglycemic effects of antidiabetics, effects blunted by NSAIDS |
|
Furosemide (Lasix)
-- Nursing Process |
* avoid giving at night--nocturia
* encourage foods high in K |
|
Enalaprilat (Vasotec)
Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: ACE inhibitor
Th Cl: anti-hypertensive PG Cl: C / D (2nd/3rd Trimester) CS Cl: N/A |
|
Enalaprilat (Vasotec)
-- Indications -- Action |
Decrease of angiotensin 2 levels: vasodilation, decr blood volume Increase of bradykinin levels: vasodilation, cough, risk of angioedema
|
|
Enalaprilat (Vasotec)
-- Typical dose adults |
Initially 5 mg po daily; usual dose 10 – 40 mg daily
|
|
Enalaprilat (Vasotec)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: cough, angioedema, first-dose hypotension, hyperkalemia,Drug Interactions: may intensify other hypotensive therapies, decreases hypoglycemic effects of antidiabetics, effects blunted by NSAIDS
|
|
Enalaprilat (Vasotec)
-- Nursing Process |
* obtain bp history before starting therapy; monitor K intake and serum K level
* educate patient about signs of angioedema (breathing difficulty, swollen lips & tongue) |
|
Nifedipine (Procardia)
Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: calcium channel blocker
Th Cl: anti-anginal PG Cl: C CS Cl: N/A |
|
Nifedipine (Procardia)
-- Indications -- Action |
Reduces B.P. and prevents angina by blocking calcium channels in peripheral arterioles lowering arterial pressure. Decreases myocardial contractility and O2 demand.
|
|
Nifedipine (Procardia)
-- Typical dose adults |
p.o. 10 – 60 mg daily
|
|
Nifedipine (Procardia)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: dizziness, headache, light-headedness, flushing, heart failure, MI, hypokalemia, pulmonary edema
Drug Interactions: quinidine, betablockers: cause hypotension DO NOT USE WITH magnesium sulfate |
|
Nifedipine (Procardia)
-- Nursing Process |
* monitor bp regularly; monitor K levels
* when quick response to drug needed: have patient bite and swallow capsule: monitor bp and ekg * temporary worsening of angina may occur at onset of therapy * ghost capsule may appear in stools |
|
Aluminum Hydroxide (Amphojel)
-- Pharmacologic class -- Therapeutic class -- Pregnancy risk category -- Controlled substance category |
Ph Cl: aluminum salt
Th Cl: antacid PG Cl: C CS Cl: N/A |
|
Aluminum Hydroxide (Amphojel)
-- Indications -- Action |
Relieves GI discomfort by reducing total acid load in GI tract, elevation in pH reduces pepsin activity; relief from peptic ulcer
|
|
Aluminum Hydroxide (Amphojel)
-- Typical dose adults |
p.o. 300 – 600 mg DO NOT GIVE WITH OTHER ORAL DRUGS
|
|
Aluminum Hydroxide (Amphojel)
-- Adverse Reactions / Drug Interactions |
Adverse Reactions: Anorexia, constipation, intestinal obstruction
Drug Interactions: interferes with absorption |
|
Aluminum Hydroxide (Amphojel)
-- Nursing Process |
* assess patient comfort before and after
* do not give w/in 2 hours of another drug * patient education: stools might have white streaks, shake suspension well and follow with a drink, how to avoid constipation * patients on low sodium diets need to use cautiously |
|
SIDE EFFECTS OF INSULIN: describe the signs/symptoms of hypoglycemia
|
* blood glucose under 50 mg/dL
* rapid drop in blood sugar may include: tachycardia, palpitations, sweating, nervousness * more gradual decrease in blood sugar may include: confusion, fatigue, drowsiness, headache, excessive hunger |
|
SIDE EFFECTS OF INSULIN: describe the signs/symptoms of hyperglycemia
|
* polyuria
* polydipsia * ketonuria * weight loss |
|
SHORT ACTING: REGULAR/SEMILENTE INSULIN
1) Time of Onset 2) Peak time 3) Duration |
1) Time of Onset: 30 - 60 min.
2) Peak time: 1 - 5 hours 3) Duration: 6 - 10 hours |
|
INTERMEDIATE ACTING (NPH/LENTE) INSULIN
1) Time of Onset 2) Peak time 3) Duration |
1) Time of Onset 1 - 2 hours
2) Peak time: 6-14 hours 3) Duration: 16 - 24 hours |
|
LONG ACTING (PZI/ULTRA LENTE)INSULIN
1) Time of Onset 2) Peak time 3) Duration |
1) Time of Onset: over 1 hour
2) Peak time: None 3) Duration 24 hours |